Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients?

Publisher: John Wiley & Sons Inc

E-ISSN: 2045-7634|7|2|317-324

ISSN: 2045-7634

Source: Cancer Medicine, Vol.7, Iss.2, 2018-02, pp. : 317-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content